Forster T, Kohler C, Dorn M, Hafner MF, et al. Non-inferiority of local control and comparable toxicity of intensity-modulated radiotherapy with simultaneous integrated boost in breast cancer: 5-year results of the IMRT-MC2 phase III trial: IMRT-SIB is non-inferior to 3-D-CRT-seqB in RT for BC pat Int J Radiat Oncol Biol Phys 2023 May 25:S0360-3016(23)00523.
PMID: 37244626